FDA Import Refusal ARE-3999665-2/10002/1 — COMPLEMENTARY COMPOUNDING PHARMACY
The FDA refused shipment ARE-3999665-2/10002/1 from COMPLEMENTARY COMPOUNDING PHARMACY (Australia) on Mar 10, 2026. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 10, 2026
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 61PDP99 ANTI-DIABETIC N.E.C.
- Charges
- 118,3280,75